Phase I trial of high-dose melphalan, high-dose etoposide and autologous bone marrow re-infusion in solid tumors: an Eastern Cooperative Oncology Group (ECOG) study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples